Search results
Results from the WOW.Com Content Network
Provide clear and concise information about the trial: Companies should communicate the terms and conditions of the free trial, including the duration, any associated costs, and the cancellation process. Offer a genuine free trial experience: A truly free trial should not require credit card information. Instead, it should allow the user to ...
Anvil Publishing, Inc., is the publishing arm of National Book Store.It publishes print books, e-books, and audiobooks. Anvil is a nationwide book dealer to network servicing dealers in the Philippines which includes National Book Store (Anvil's parent company), Goodwill Book Store, Rex Book Store, and Solidaridad.
Adarna House also offers book development services to individuals and institutions out to commission the production of a book project. The services include copy writing, editing, research, illustration, art direction, and printing.
A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer drug ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
AstraZeneca is advancing early stage trials of several cell therapies in different types of cancer including liver and prostate cancer. (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak ...
Vibal Publishing House, Inc. (also known as Vibal Group, Inc., Vibal, or VPHI) is a major publishing house in the Philippines based in Quezon City. Vibal was founded in 1953 by Hilarion P. Vibal and by his wife, Esther Asuncion-Vibal. [1] Vibal is a textbook, reference materials, and multimedia products publisher and is the biggest in the country.
(Reuters) -AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, starting June, following a similar move by rival ...